TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry.

Chandrasekhar, J; Baber, U; Sartori, S; Pinnelas, R; Henry, T; Moliterno, D; Cohen, D; Weisz, G; Kini, A; Bruckel, J; +10 more... Pocock, S; Steg, PG; Witzenbichler, B; Colombo, A; Chieffo, A; Iakovou, I; Dangas, G; Gibson, CM; Stuckey, T; Mehran, R; (2016) TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry. Elsevier. DOI: https://doi.org/10.1016/j.jacc.2016.09.262

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jacc.2016.09.262

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar